Skip to content
AwardedCzechiaGoodsCZK 47,173,520

Dodávky léků – Léčivá látka denosumab o síle 120MG pro onkologické indikace – ATC M05BX04

Published
Published 6 May 2025
Deadline
Closed 5 June 2025

Overview

Předmětem plnění Veřejné zakázky jsou průběžné dodávky léčivého přípravku s obsahem léčivé látky denosumab o síle 120MG určeného pro onkologické indikace – ATC M05BX04. LL – denosumab , léková forma 120MG INJ SOL ISP 1X1ML, měrná jednotka 1X1ML/120MG, množství 8 000

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 47,173,520
Procedure
Open
SME suitable
Yes
Published
6 May 2025
Deadline
Closed
Classification (CPV)
Medicinal products for the musculo-skeletal system

Award outcome

Awarded value
CZK 47,173,520
Award date
10 June 2025
Contract period
17 June 2025 → 16 June 2029
Winner
  • Amgen s.r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    19 June 2025

  2. Contract Notice

    6 May 2025

Contracting authority

  • Fakultní Thomayerova nemocnice

    Procuring entity

    Praha, Czechia

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Dodávky léků – Léčivá látka denosumab o síle 120MG pro onkologické indikace – ATC M05BX04 — won by Amgen s.r.o. — Skim